The protective effect of tanshinone IIa on endothelial cells: a generalist among clinical therapeutics

References

• X-d ME, Cao Y-F, Che -Y-Y, et al. Danshen: a phytochemical and pharmacological overview. Chin J Nat Med. 2019;17(1):59–80.
   PubMed Web of Science ®Google Scholar
• Li ZM, Xu SW, Liu PQ. Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics. Acta Pharmacol Sin. 2018;39(5):802–824.
   PubMed Web of Science ®Google Scholar
• Chen W, Chen G. Danshen (salvia miltiorrhiza bunge): a prospective healing sage for cardiovascular diseases. Curr Pharm Des. 2017;23(34):5125–5135. .
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang P, Ye M, et al. Tanshinones: sources, pharmacokinetics and anti-cancer activities. Int J Mol Sci. 2012;13(10):13621–13666.
   PubMed Web of Science ®Google Scholar
• Ying Q, Teng Y, Zhang J, et al. Therapeutic effect of tanshinone iia on liver fibrosis and the possible mechanism: a preclinical meta-analysis. Evid Based Complement Alternat Med. 2019;2019:7514046. .
   PubMed Web of Science ®Google Scholar
• Zhou ZY, Zhao WR, Zhang J, et al. Sodium tanshinone IIA sulfonate: a review of pharmacological activity and pharmacokinetics. Biomed Pharmacothe. 2019;118:109362. .
   PubMed Web of Science ®Google Scholar
• Luo C, Xu X, Wei X, et al. Natural medicines for the treatment of fatigue: bioactive components, pharmacology, and mechanisms. Pharmacol Res. 2019;148:104409.
   PubMed Web of Science ®Google Scholar
• Tian XH, Wu JH. Tanshinone derivatives: a patent review (January 2006 - September 2012). Expert Opin Ther Pat. 2013;23(1):19–29.
   PubMed Web of Science ®Google Scholar
• Qin WW, Wang L, Jiao Z, et al. Lower clearance of sodium tanshinone IIA sulfonate in coronary heart disease patients and the effect of total bilirubin: a population pharmacokinetics analysis. Chin J Nat Med. 2019;17(3):218–226.
   PubMed Web of Science ®Google Scholar
• Kruger-Genge A, Blocki A, Franke RP, et al. Vascular endothelial cell biology: an update. Int J Mol Sci. 2019;20(18):4411.
   PubMed Web of Science ®Google Scholar
• van Hinsbergh VW. Endothelium–role in regulation of coagulation and inflammation. Semin Immunopathol. 2012;34(1):93–106.
   PubMed Web of Science ®Google Scholar
• Gudmundsdottir IJ, Lang NN, Boon NA, et al. Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans. J Am Coll Cardiol. 2008;51(18):1749–1756.
   PubMed Web of Science ®Google Scholar
• Boucher P, Matz RL, Terrand J. atherosclerosis: gone with the wnt? Atherosclerosis. 2020;301:15–22.
   PubMed Web of Science ®Google Scholar
• Yang D, Yang Z, Chen L, et al. Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA-21 in apolipoprotein E-deficient mice. J Cell Mol Med. 2020;24(10):5911-5925.
   Web of Science ®Google Scholar
• Chistiakov DA, Orekhov AN, Bobryshev YV. Vascular smooth muscle cell in atherosclerosis. Acta Physiol. 2015;214(1):33–50.
   PubMed Web of Science ®Google Scholar
• Badimon L, Padro T, Vilahur G. Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. Eur Heart J Acute Cardiovasc Care. 2012;1(1):60–74.
   PubMedGoogle Scholar
• Kattoor AJ, Kanuri SH, Mehta JL. Role of Ox-LDL and LOX-1 in Atherogenesis. Curr Med Chem. 2019;26(9):1693–1700.
   PubMed Web of Science ®Google Scholar
• Toda N, Nakanishi-Toda M. How mental stress affects endothelial function. Pflugers Arch. 2011;462(6):779–794.
   PubMed Web of Science ®Google Scholar
• Shah P, Khaleel M, Thuptimdang W, et al. Mental stress causes vasoconstriction in subjects with sickle cell disease and in normal controls. Haematologica. 2020;105(1):83–90.
   PubMed Web of Science ®Google Scholar
• Hahad O, Prochaska JH, Daiber A, et al. Effects on stress hormones, oxidative stress, and vascular dysfunction: key factors in the relationship between cerebrocardiovascular and psychological disorders. Oxid Med Cell Longev. 2019;2019:4623109.
   PubMed Web of Science ®Google Scholar
• Daiber A, Kroller-Schon S, Oelze M, et al. Oxidative stress and inflammation contribute to traffic noise-induced vascular and cerebral dysfunction via uncoupling of nitric oxide synthases. Redox Biol. 2020;34:101506.
   PubMed Web of Science ®Google Scholar
• Munzel T, Sorensen M, Schmidt F, et al. The adverse effects of environmental noise exposure on oxidative stress and cardiovascular risk. Antioxid Redox Signal. 2018;28(9):873–908.
   PubMed Web of Science ®Google Scholar
• Dhananjayan R, Koundinya KS, Malati T, et al. Endothelial dysfunction in type 2 diabetes mellitus. Indian J Clin Biochem. 2016;31(4):372–379.
   PubMed Web of Science ®Google Scholar
• Potenza MA, Gagliardi S, Nacci C, et al. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem. 2009;16(1):94–112. .
   PubMed Web of Science ®Google Scholar
• Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(23Suppl 1):III27–32.
   PubMedGoogle Scholar
• Larose E, Ganz P. Statins and endothelial dysfunction. Semin Vasc Med. 2004;4(4):333–346.
   PubMedGoogle Scholar
• Ren J, Fu L, Nile SH, et al. Salvia miltiorrhiza in treating cardiovascular diseases: a review on its pharmacological and clinical applications. Front Pharmacol. 2019;10(753). DOI:10.3389/fphar.2019.00753
   Google Scholar
• Zhang GX, Zhang YY, Zhang XX, et al. Different network pharmacology mechanisms of Danshen-based Fangjis in the treatment of stable angina. Acta Pharmacol Sin. 2018;39(6):952–960.
   PubMed Web of Science ®Google Scholar
• Gao S, Liu Z, Li H, et al. Cardiovascular actions and therapeutic potential of tanshinone IIA. Atherosclerosis. 2012;220(1):3–10.
   PubMed Web of Science ®Google Scholar
• Adams JD, Wang R, Yang J, et al. Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions. Chin Med. 2006;1(1):3.
   PubMedGoogle Scholar
• Chan P, Chen YC, Lin LJ, et al. Tanshinone IIA Attenuates H(2)O(2) -induced injury in human umbilical vein endothelial cells. Am J Chin Med. 2012;40(6):1307–1319.
   PubMed Web of Science ®Google Scholar
• Bi X, Zhang K, He L, et al. Synthesis and biological evaluation of tanshinone IIA derivatives as novel endothelial protective agents. Future Med Chem. 2017;9(10):1073–1085.
   PubMed Web of Science ®Google Scholar
• Yang JX, Pan YY, Ge JH, et al. Tanshinone II A attenuates TNF-alpha-induced expression of VCAM-1 and ICAM-1 in endothelial progenitor cells by blocking activation of NF-kappaB. Cell Physiol Biochem. 2016;40(1–2):195–206.
   PubMedGoogle Scholar
• Zhong L, Simard MJ, Huot J. Endothelial microRNAs regulating the NF-kappaB pathway and cell adhesion molecules during inflammation. Faseb J. 2018;32(8):4070–4084.
   PubMed Web of Science ®Google Scholar
• Chen L, Guo QH, Chang Y, et al. Tanshinone IIA ameliorated endothelial dysfunction in rats with chronic intermittent hypoxia. Cardiovascular pathology: the official journal of the Society for Cardiovascular Pathology. 2017;31: 47–53.
   PubMed Web of Science ®Google Scholar
• Li YH, Xu Q, Xu WH, et al. Mechanisms of protection against diabetes-induced impairment of endothelium-dependent vasorelaxation by Tanshinone IIA. Biochim Biophys Acta. 2015;1850(4):813–823.
   PubMed Web of Science ®Google Scholar
• Zhou ZW, Xie XL, Zhou SF, et al. Mechanism of reversal of high glucose-induced endothelial nitric oxide synthase uncoupling by tanshinone IIA in human endothelial cell line EA.hy926. Eur J Pharmacol. 2012;697(1–3):97–105.
   PubMed Web of Science ®Google Scholar
• Chen F, Li H, Zhu G, et al. Sodium tanshinone IIA sulfonate improves inflammation, aortic endothelial cell apoptosis, disseminated intravascular coagulation and multiple organ damage in a rat heat stroke model. Mol Med Rep. 2017;16(1):87–94.
   PubMed Web of Science ®Google Scholar
• Xu RH, Liu B, Wu JD, et al. miR-143 is involved in endothelial cell dysfunction through suppression of glycolysis and correlated with atherosclerotic plaques formation. Eur Rev Med Pharmacol Sci. 2016;20(19):4063–4071.
   PubMed Web of Science ®Google Scholar
• Huang R, Hu Z, Cao Y, et al. MiR-652-3p inhibition enhances endothelial repair and reduces atherosclerosis by promoting Cyclin D2 expression. EBioMedicine. 2019;40:685–694.
   PubMed Web of Science ®Google Scholar
• Lu M, Luo Y, Hu P, et al. Tanshinone IIA inhibits AGEs-induced proliferation and migration of cultured vascular smooth muscle cells by suppressing ERK1/2 MAPK signaling. Iran J Basic Med Sci. 2018;21(1):83–88.
   PubMed Web of Science ®Google Scholar
• Wu WY, Yan H, Wang XB, et al. Sodium tanshinone IIA silate inhibits high glucose-induced vascular smooth muscle cell proliferation and migration through activation of AMP-activated protein kinase. PloS One. 2014;9(4):e94957.
   PubMed Web of Science ®Google Scholar
• Wang B, Ge Z, Cheng Z, et al. IIA suppresses the progression of atherosclerosis by inhibiting the apoptosis of vascular smooth muscle cells and the proliferation and migration of macrophages induced by ox-LDL. Biol Open. 2017;6(4):489–495.
   PubMed Web of Science ®Google Scholar
• Meng ZJ, Wang C, Meng LT, et al. Sodium tanshinone IIA sulfonate attenuates cardiac dysfunction and improves survival of rats with cecal ligation and puncture-induced sepsis. Chin J Nat Med. 2018;16(11):846–855.
   PubMed Web of Science ®Google Scholar
• Wei B, Li WW, Ji J, et al. The cardioprotective effect of sodium tanshinone IIA sulfonate and the optimizing of therapeutic time window in myocardial ischemia/reperfusion injury in rats. Atherosclerosis. 2014;235(2):318–327.
   PubMed Web of Science ®Google Scholar
• Yan SH, Zhao NW, Geng ZR, et al. Modulations of keap1-nrf2 signaling axis by TIIA ameliorated the oxidative stress-induced myocardial apoptosis. Free Radic Biol Med. 2018;115:191–201.
   PubMed Web of Science ®Google Scholar
• Grobe AC, Wells SM, Benavidez E, et al. Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: role of NADPH oxidase and endothelial NO synthase. Am J Physiol Lung Cell Mol Physiol. 2006;290(6):L1069–77.
   PubMed Web of Science ®Google Scholar
• Harper E, Rochfort KD, Smith D, et al. RANKL treatment of vascular endothelial cells leading to paracrine pro-calcific signaling involves ROS production. Mol Cell Biochem. 2020;464(1–2):111–117.
   PubMed Web of Science ®Google Scholar
• Jaganjac M, Cipak A, Schaur RJ, et al. Pathophysiology of neutrophil-mediated extracellular redox reactions. Front Biosci (Landmark Ed). 2016;21(4):839–855.
   PubMedGoogle Scholar
• Vallet B, Wiel E. Endothelial cell dysfunction and coagulation. Crit Care Med. 2001;29(7Suppl):S36–41.
   PubMedGoogle Scholar
• Jiang Z, Gao W, Tanshinones HL. Critical pharmacological components in salvia miltiorrhiza. Front Pharmacol. 2019;10:202.
   PubMed Web of Science ®Google Scholar
• Ma XH, Ma Y, Tang JF, et al. The biosynthetic pathways of tanshinones and phenolic acids in salvia miltiorrhiza. Molecules. 2015;20(9):16235–16254.
   PubMed Web of Science ®Google Scholar
• Yang L, Zou XJ, Gao X, et al. Sodium tanshinone IIA sulfonate attenuates angiotensin II-induced collagen type I expression in cardiac fibroblasts in vitro. Exp Mol Med. 2009;41(7):508–516.
   PubMed Web of Science ®Google Scholar
• Wang P, Zhou S, Xu L, et al. Hydrogen peroxide-mediated oxidative stress and collagen synthesis in cardiac fibroblasts: blockade by tanshinone IIA. J Ethnopharmacol. 2013;145(1):152–161.
   PubMed Web of Science ®Google Scholar
• Wang P, Wu X, Bao Y, et al. Tanshinone IIA prevents cardiac remodeling through attenuating NAD (P)H oxidase-derived reactive oxygen species production in hypertensive rats. Pharmazie. 2011;66(7):517–524.
   PubMed Web of Science ®Google Scholar
• Agarwal B, Dash RK, Stowe DF, et al. Isoflurane modulates cardiac mitochondrial bioenergetics by selectively attenuating respiratory complexes. Biochim Biophys Acta. 2014;1837(3):354–365.
   PubMed Web of Science ®Google Scholar
• Zhou G, Jiang W, Zhao Y, et al. Sodium tanshinone IIA sulfonate mediates electron transfer reaction in rat heart mitochondria. Biochem Pharmacol. 2003;65(1):51–57.
   PubMed Web of Science ®Google Scholar
• Dong K, Xu W, Yang J, et al. Neuroprotective effects of Tanshinone IIA on permanent focal cerebral ischemia in mice. Phytother Res. 2009;23(5):608–613.
   PubMed Web of Science ®Google Scholar
• Tong W, Guo J, Tanshinone YC. II A enhances prypotosis and represses cell proliferation of Hela cells by regulating miR-145/GSDMD signaling pathway. Biosci Rep. 2020. DOI:10.1042/BSR20200259
   Web of Science ®Google Scholar
• Zhou ZY, Huang B, Li S, et al. Sodium tanshinone IIA sulfonate promotes endothelial integrity via regulating VE-cadherin dynamics and RhoA/ROCK-mediated cellular contractility and prevents atorvastatin-induced intracerebral hemorrhage in zebrafish. Toxicol Appl Pharmacol. 2018;350:32–42.
   PubMed Web of Science ®Google Scholar
• Qian C, Ren Y, Xia Y. Sodium tanshinone IIA sulfonate attenuates hemorrhagic shock-induced organ damages by nuclear factor-kappa B pathway. J Surg Res. 2017;209:145–152.
   PubMed Web of Science ®Google Scholar
• Zhu S, Wei W, Liu Z, et al. TanshinoneIIA attenuates the deleterious effects of oxidative stress in osteoporosis through the NFkappaB signaling pathway. Mol Med Rep. 2018;17(5):6969–6976.
   PubMed Web of Science ®Google Scholar
• Zhong L, Ding W, Zeng Q, et al. Sodium tanshinone IIA sulfonate attenuates erectile dysfunction in rats with hyperlipidemia. Oxid Med Cell Longev. 2020;2020:7286958.
   PubMed Web of Science ®Google Scholar
• Yin CF, Kao SC, Hsu CL, et al. Phosphoproteome analysis reveals dynamic heat shock protein 27 phosphorylation in tanshinone IIA-induced cell death. J Proteome Res. 2020;19(4):1620–1634.
   PubMed Web of Science ®Google Scholar
• Dong DL, Bai YL, Cai BZ. Calcium-activated potassium channels: potential target for cardiovascular diseases. Adv Protein Chem Struct Biol. 2016;104:233–261.
   PubMed Web of Science ®Google Scholar
• Blum-Johnston C, Thorpe RB, Wee C, et al. Long-term hypoxia uncouples Ca(2+) and eNOS in bradykinin-mediated pulmonary arterial relaxation. Am J Physiol Regul Integr Comp Physiol. 2018;314(6):R870–R82.
   PubMed Web of Science ®Google Scholar
• Wilson C, Zhang X, Buckley C, et al. Increased vascular contractility in hypertension results from impaired endothelial calcium signaling. Hypertension. 2019;74(5):1200–1214.
   PubMed Web of Science ®Google Scholar
• Wei R, Lunn SE, Tam R, et al. Vasoconstrictor stimulus determines the functional contribution of myoendothelial feedback to mesenteric arterial tone. J Physiol. 2018;596(7):1181–1197.
   PubMed Web of Science ®Google Scholar
• Kerr PM, Wei R, Tam R, et al. Activation of endothelial IKCa channels underlies NO-dependent myoendothelial feedback. Vascul Pharmacol. 2015;74:130–138.
   PubMed Web of Science ®Google Scholar
• Behringer EJ. Calcium and electrical signaling in arterial endothelial tubes: new insights into cellular physiology and cardiovascular function. Microcirculation. 2017;24(3):e12328.
   PubMed Web of Science ®Google Scholar
• Coleman HA, Tare M, Parkington HC. Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease. Clin Exp Pharmacol Physiol. 2004;31(9):641–649.
   PubMed Web of Science ®Google Scholar
• Tan X, Yang Y, Cheng J, et al. Unique action of sodium tanshinone II-A sulfonate (DS-201) on the Ca(2+) dependent BK(Ca) activation in mouse cerebral arterial smooth muscle cells. Eur J Pharmacol. 2011;656(1–3):27–32.
   PubMed Web of Science ®Google Scholar
• Yang Y, Cai F, Li PY, et al. Activation of high conductance Ca(2+)-activated K(+) channels by sodium tanshinoneII-A sulfonate (DS-201) in porcine coronary artery smooth muscle cells. Eur J Pharmacol. 2008;598(1–3):9–15.
   PubMed Web of Science ®Google Scholar
• Zheng L, Liu M, Wei M, et al. Tanshinone IIA attenuates hypoxic pulmonary hypertension via modulating KV currents. Respir Physiol Neurobiol. 2015;205:120–128.
   PubMed Web of Science ®Google Scholar
• Xie XY, Zhang B, Li JH, et al. Sodium tanshinone iia sulfonate attenuates seawater aspiration-induced acute pulmonary edema by up-regulating Na(+),K(+)-ATPase activity. Exp Lung Res. 2011;37(8):482–491.
   PubMed Web of Science ®Google Scholar
• Yu W, Jin H, Tang C, et al. Sulfur-containing gaseous signal molecules, ion channels and cardiovascular diseases. Br J Pharmacol. 2018;175(8):1114–1125.
   PubMed Web of Science ®Google Scholar
• Zhang YL, Xu JW, Wu XH, et al. Relaxant effect of sodium tanshinone iia sulphonate on mouse tracheal smooth muscle. Planta Med. 2017;83(7):624–630.
   PubMed Web of Science ®Google Scholar
• Xie MJ, Ma YG, Gao F, et al. Activation of BKCa channel is associated with increased apoptosis of cerebrovascular smooth muscle cells in simulated microgravity rats. Am J Physiol Cell Physiol. 2010;298(6):C1489–500.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li M, Song M, et al. Clic1 plays a role in mouse hepatocarcinoma via modulating Annexin A7 and Gelsolin in vitro and in vivo. Biomed Pharmacothe. 2015;69:416–419.
   PubMed Web of Science ®Google Scholar
• Chen PX, Zhang YL, Xu JW, et al. Sodium tanshinone IIA sulfonate stimulated Cl- secretion in mouse trachea. PloS One. 2017;12(5):e0178226.
   PubMed Web of Science ®Google Scholar
• Zhu J, Xu Y, Ren G, et al. Tanshinone IIA Sodium sulfonate regulates antioxidant system, inflammation, and endothelial dysfunction in atherosclerosis by downregulation of CLIC1. Eur J Pharmacol. 2017;815:427–436.
   PubMed Web of Science ®Google Scholar
• Cao Y, Gong Y, Liu L, et al. The use of human umbilical vein endothelial cells (HUVECs) as an in vitro model to assess the toxicity of nanoparticles to endothelium: a review. J Appl Toxicol. 2017;37(12):1359–1369.
   PubMed Web of Science ®Google Scholar
• Zhao M, Feng Y, Xiao J, et al. Sodium tanshinone IIA sulfonate prevents hypoxic trophoblast-induced endothelial cell dysfunction via targeting HMGB1 release. J Biochem Mol Toxicol. 2017;31(7).
   Web of Science ®Google Scholar
• Li FQ, Zeng DK, Jia CL, et al. The effects of sodium tanshinone IIa sulfonate pretreatment on high glucose-induced expression of fractalkine and apoptosis in human umbilical vein endothelial cells. Int J Clin Exp Med. 2015;8(4):5279–5286.
   PubMed Web of Science ®Google Scholar
• Long R, You Y, Li W, et al. Sodium tanshinone IIA sulfonate ameliorates experimental coronary no-reflow phenomenon through down-regulation of FGL2. Life Sci. 2015;142:8–18.
   PubMed Web of Science ®Google Scholar
• Cheng J, Chen T, Li P, et al. Sodium tanshinone IIA sulfonate prevents lipopolysaccharide-induced inflammation via suppressing nuclear factor-kappaB signaling pathway in human umbilical vein endothelial cells. Can J Physiol Pharmacol. 2018;96(1):26–31.
   PubMed Web of Science ®Google Scholar
• Olea FD, Vera Janavel G, Cuniberti L, et al. Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia. Gene Ther. 2009;16(6):716–723.
   PubMed Web of Science ®Google Scholar
• Signorelli SS, Vanella L, Abraham NG, et al. Pathophysiology of chronic peripheral ischemia: new perspectives. Ther Adv Chronic Dis. 2020;11:2040622319894466.
   Web of Science ®Google Scholar
• Fuentes E, Gibbins JM, Holbrook LM, et al. NADPH oxidase 2 (NOX2): a key target of oxidative stress-mediated platelet activation and thrombosis. Trends Cardiovasc Med. 2018;28(7):429–434.
   PubMed Web of Science ®Google Scholar
• Olea FD, Locatelli P, Hnatiuk A, et al. Vascular endothelial growth factor overexpression does not enhance adipose stromal cell-induced protection on muscle damage in critical limb ischemia. Arterioscler Thromb Vasc Biol. 2015;35(1):184–188.
   PubMed Web of Science ®Google Scholar
• Kalka C, Masuda H, Takahashi T, et al. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res. 2000;86(12):1198–1202.
   PubMed Web of Science ®Google Scholar
• Baumgartner I. Therapeutic angiogenesis: theoretic problems using vascular endothelial growth factor. Curr Cardiol Rep. 2000;2(1):24–28.
   PubMedGoogle Scholar
• Xu Z, Wu L, Sun Y, et al. Tanshinone IIA pretreatment protects free flaps against hypoxic injury by upregulating stem cell-related biomarkers in epithelial skin cells. BMC Complement Altern Med. 2014;14(1):331.
   PubMedGoogle Scholar
• Li Z, Zhang S, Cao L, et al. Tanshinone IIA and Astragaloside IV promote the angiogenesis of mesenchymal stem cell-derived endothelial cell-like cells via upregulation of Cx37, Cx40 and Cx43. Exp Ther Med. 2018;15(2):1847–1854.
   PubMed Web of Science ®Google Scholar
• Incalza MA, D’Oria R, Natalicchio A, et al. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul Pharmacol. 2018;100:1–19.
   PubMed Web of Science ®Google Scholar
• Wang WQ, Liu L, Sun HC, et al. Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization. J Hematol Oncol. 2012;5(1):69.
   PubMedGoogle Scholar
• Li D, Wang J, Sun D, et al. Tanshinone IIA sulfonate protects against cigarette smoke-induced COPD and down-regulation of CFTR in mice. Sci Rep. 2018;8(1):376.
   PubMedGoogle Scholar
• Li D, Sun D, Yuan L, et al. Sodium tanshinone IIA sulfonate protects against acute exacerbation of cigarette smoke-induced chronic obstructive pulmonary disease in mice. Int Immunopharmacol. 2020;81:106261.
   PubMed Web of Science ®Google Scholar
• Guan R, Wang J, Li Z, et al. Sodium tanshinone IIA sulfonate decreases cigarette smoke-induced inflammation and oxidative stress via blocking the activation of MAPK/HIF-1alpha signaling pathway. Front Pharmacol. 2018;9:263.
   PubMed Web of Science ®Google Scholar
• Chen L, Wei L, Yu Q, et al. Tanshinone IIA alleviates hypoxia/reoxygenation induced cardiomyocyte injury via lncRNA AK003290/miR-124-5p signaling. BMC molecular and cell biology. 2020;21(1):20.
   PubMed Web of Science ®Google Scholar
• Cui ZT, Liu JP, Wei WL. The effects of tanshinone IIA on hypoxia/reoxygenation-induced myocardial microvascular endothelial cell apoptosis in rats via the JAK2/STAT3 signaling pathway. Biomed Pharmacothe. 2016;83:1116–1126.
   PubMed Web of Science ®Google Scholar
• Huang YF, Liu ML, Dong MQ, et al. Effects of sodium tanshinone II A sulphonate on hypoxic pulmonary hypertension in rats in vivo and on Kv2.1 expression in pulmonary artery smooth muscle cells in vitro. J Ethnopharmacol. 2009;125(3):436–443.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Lu W, Yang K, et al. Sodium tanshinone IIA sulfonate inhibits hypoxia-induced enhancement of SOCE in pulmonary arterial smooth muscle cells via the PKG-PPAR-gamma signaling axis. Am J Physiol Cell Physiol. 2016;311(1):C136–49.
   PubMed Web of Science ®Google Scholar
• Xu Z, Zhang Z, Wu L, et al. Tanshinone IIA pretreatment renders free flaps against hypoxic injury through activating Wnt signaling and upregulating stem cell-related biomarkers. Int J Mol Sci. 2014;15(10):18117–18130.
   PubMed Web of Science ®Google Scholar
• Yadav S, Singh M, Singh SN, et al. Tanshinone IIA pretreatment promotes cell survival in human lung epithelial cells under hypoxia via AP-1-Nrf2 transcription factor. Cell Stress Chaperones. 2020;25(3):427–440.
   Web of Science ®Google Scholar
• Xie Z, Zhou Y, Duan X, et al. Inhibitory effect of Tanshinone IIA on inverted formin-2 protects HaCaT cells against oxidative injury via regulating mitochondrial stress. J Recept Signal Transduct Res. 2019;39(2):134–145.
   PubMed Web of Science ®Google Scholar
• Qi D, Wang M, Zhang D, et al. Tanshinone IIA protects lens epithelial cells from H2O2-induced injury by upregulation of lncRNA ANRIL. J Cell Physiol. 2019;234(9):15420–15428.
   Web of Science ®Google Scholar
• Kandilis AN, Karidis NP, Kouraklis G, et al. Proteasome inhibitors: possible novel therapeutic strategy for ischemia-reperfusion injury? Expert Opin Investig Drugs. 2014;23(1):67–80.
   PubMed Web of Science ®Google Scholar
• Zhang L, An GY, Zhang WG, et al. Effects of tanshinone- II A sulfonate on expression of nuclear factor-kappaB, vascular cell adhesion molecule-1 and hemorrheology during spinal cord ischemia reperfusion injury. Zhongguo Gu Shang. 2012;25(12):1016–1020.
   PubMedGoogle Scholar
• Liu S, Wang K, Duan X, et al. Efficacy of danshen class injection in the treatment of acute cerebral infarction: a bayesian network meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2019;2019:5814749.
   PubMedGoogle Scholar
• Ji B, Zhou F, Han L, et al. Sodium tanshinone iia sulfonate enhances effectiveness rt-PA treatment in acute ischemic stroke patients associated with ameliorating blood-brain barrier damage. Transl Stroke Res. 2017;8(4):334–340.
   PubMed Web of Science ®Google Scholar
• Maione F, De Feo V, Caiazzo E, et al. Tanshinone IIA, a major component of Salvia milthorriza Bunge, inhibits platelet activation via Erk-2 signaling pathway. J Ethnopharmacol. 2014;155(2):1236–1242.
   PubMed Web of Science ®Google Scholar
• Fei YX, Wang SQ, Yang LJ, et al. Salvia miltiorrhiza Bunge (Danshen) extract attenuates permanent cerebral ischemia through inhibiting platelet activation in rats. J Ethnopharmacol. 2017;207:57–66.
   PubMed Web of Science ®Google Scholar
• Li Y, Guo Y, Chen Y, et al. Establishment of an interleukin-1beta-induced inflammation-activated endothelial cell-smooth muscle cell-mononuclear cell co-culture model and evaluation of the anti-inflammatory effects of tanshinone IIA on atherosclerosis. Mol Med Rep. 2015;12(2):1665–1676.
   PubMed Web of Science ®Google Scholar
• Ma S, Wang X, Wang Y, et al. Sodium tanshinone IIA sulfonate improves hemodynamic parameters, cytokine release, and multi-organ damage in endotoxemia rabbits. Med Sci Monit. 2018;24:2975–2982.
   PubMed Web of Science ®Google Scholar
• Zhu W, Lu Q, Chen HW, et al. Protective effect of sodium tanshinone IIA sulfonate on injury of small intestine in rats with sepsis and its mechanism. Chin J Integr Med. 2012;18(7):496–501.
   PubMed Web of Science ®Google Scholar
• Zhu W, Lu Q, Wan L, et al. Sodium tanshinone II A sulfonate ameliorates microcirculatory disturbance of small intestine by attenuating the production of reactive oxygen species in rats with sepsis. Chin J Integr Med. 2016;22(10):745–751.
   PubMed Web of Science ®Google Scholar
• Feng F, Cheng P, Xu S, et al. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-beta1/Smad signaling. Chem Biol Interact. 2020;319:109024.
   PubMed Web of Science ®Google Scholar
• Divya T, Velavan B, Sudhandiran G. Regulation of transforming growth factor-beta/smad-mediated epithelial-mesenchymal transition by celastrol provides protection against bleomycin-induced pulmonary fibrosis. Basic Clin Pharmacol Toxicol. 2018;123(2):122–129.
   PubMed Web of Science ®Google Scholar
• Chen T, Li M, Fan X, et al. Sodium tanshinone IIA sulfonate prevents angiotensin II-induced differentiation of human atrial fibroblasts into myofibroblasts. Oxid Med Cell Longev. 2018;2018:6712585.
   PubMed Web of Science ®Google Scholar
• Singh S, Torzewski M. Fibroblasts and their pathological functions in the fibrosis of aortic valve sclerosis and atherosclerosis. Biomolecules. 2019;9(9):472. .
   Web of Science ®Google Scholar
• Jiang Y, Hu F, Li Q, et al. Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis. Int Immunopharmacol. 2019;77:105968.
   PubMed Web of Science ®Google Scholar
• Tang H, He H, Ji H, et al. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-beta-dependent epithelial to mesenchymal transition. J Surg Res. 2015;197(1):167–175.
   PubMed Web of Science ®Google Scholar
• Shi MJ, Yan XL, Dong BS, et al. A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis. J Ethnopharmacol. 2020;253:112689.
   PubMed Web of Science ®Google Scholar
• Chunming J, Miao Z, Cheng S, et al. Tanshinone IIA attenuates peritoneal fibrosis through inhibition of fibrogenic growth factors expression in peritoneum in a peritoneal dialysis rat model. Ren Fail. 2011;33(3):355–362.
   PubMed Web of Science ®Google Scholar
• Bitker L, Burrell LM. Classic and nonclassic renin-angiotensin systems in the critically ill. Crit Care Clin. 2019;35(2):213–227.
   PubMed Web of Science ®Google Scholar
• Zhuo JL, Li XC. New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II. Peptides. 2011;32(7):1551–1565.
   PubMed Web of Science ®Google Scholar
• Zhang J, Cai Z, Yang M, et al. Inhibition of tanshinone IIA on renin activity protected against osteoporosis in diabetic mice. Pharm Biol. 2020;58(1):219–224.
   PubMed Web of Science ®Google Scholar
• Chen ZZ, Gong X. Tanshinone IIA contributes to the pathogenesis of endometriosis via renin angiotensin system by regulating the dorsal root ganglion axon sprouting. Life Sci. 2020;240:117085.
   PubMed Web of Science ®Google Scholar
• Yu LZ, Shi CR. Effect of tanshinone II(A) on expression of different components in renin-angiotensin system of left ventricles of hypertensive rats. Zhongguo Zhong Yao Za Zhi. 2014;39(8):1468–1472.
   PubMedGoogle Scholar
• Li YS, Liang QS, Wang J. Effect of tanshinone II A on angiotensin II induced nitric oxide production and endothelial nitric oxide synthase gene expression in cultured porcine aortic endothelial cells. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007;27(7):637–639.
   PubMedGoogle Scholar
• Chan P, Liu JC, Lin LJ, et al. Tanshinone IIA inhibits angiotensin II-induced cell proliferation in rat cardiac fibroblasts. Am J Chin Med. 2011;39(2):381–394.
   PubMed Web of Science ®Google Scholar